Bank of Montreal
MIST icon

Bank of Montreal’s Milestone Pharmaceuticals MIST Stock Holding History

Bank of Montreal’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-273,100
Closed -$787K – 4108
2024
Q1 		$787K Buy
+273,100
New +$443K ﹤0.01% 2143
2023
Q1 		– Sell
-152,636
Closed -$611K – 4038
2022
Q4 		$611K Buy
152,636
+104,536
+217% +$550K ﹤0.01% 2495
2022
Q3 		$446 Buy
+48,100
New +$365K ﹤0.01% 2648

Other funds holding MIST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bank of Montreal's MIST Position: Q2 2024 in Review

Bank of Montreal sold out of Milestone Pharmaceuticals (MIST) in Q2 2024, closing a stake of 273,100 shares — an estimated $787K sold.

Bank of Montreal first reported a position in MIST in Q3 2022 and held it in 3 quarters. The position peaked at $787K in Q1 2024. 40 funds tracked by Wall St. Rank hold MIST as of Q2 2024.

  • Bank of Montreal reported no remaining Milestone Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 273,100 Milestone Pharmaceuticals shares in Q2 2024, an estimated $787K.
  • Bank of Montreal first reported a position in Milestone Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Bank of Montreal's Milestone Pharmaceuticals position peaked at $787K in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.